ResMed Inc. RSMDF Stock
ResMed Inc. Price Chart
ResMed Inc. RSMDF Financial and Trading Overview
| ResMed Inc. stock price | 16.99 USD |
| Previous Close | 16.99 USD |
| Open | 20.06 USD |
| Bid | 16.38 USD x 10000 |
| Ask | 21.37 USD x 10000 |
| Day's Range | 20.06 - 20.06 USD |
| 52 Week Range | 11.85 - 28.25 USD |
| Volume | 13 USD |
| Avg. Volume | 88 USD |
| Market Cap | 29.1B USD |
| Beta (5Y Monthly) | 0.782 |
| PE Ratio (TTM) | 19.288462 |
| EPS (TTM) | 1.04 USD |
| Forward Dividend & Yield | 0.24 (1.40%) |
| Ex-Dividend Date | May 13, 2026 |
| 1y Target Est | N/A |
RSMDF Valuation Measures
| Enterprise Value | 9.04B USD |
| Trailing P/E | 19.288462 |
| Forward P/E | 48.92683 |
| PEG Ratio (5 yr expected) | 1 |
| Price/Sales (ttm) | 5.2544994 |
| Price/Book (mrq) | 1.7927121 |
| Enterprise Value/Revenue | 1.633 |
| Enterprise Value/EBITDA | 4.265 |
Trading Information
ResMed Inc. Stock Price History
| Beta (5Y Monthly) | 0.782 |
| 52-Week Change | -22.77% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 28.25 USD |
| 52 Week Low | 11.85 USD |
| 50-Day Moving Average | 20.19 USD |
| 200-Day Moving Average | 24.31 USD |
RSMDF Share Statistics
| Avg. Volume (3 month) | 88 USD |
| Avg. Daily Volume (10-Days) | 36 USD |
| Shares Outstanding | 1.45B |
| Float | 576.64M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 8.39% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.33 |
| Trailing Annual Dividend Yield | 13.71% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.22469999 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | 27.43% |
| Operating Margin (ttm) | 35.32% |
| Gross Margin | 62.18% |
| EBITDA Margin | 38.27% |
Management Effectiveness
| Return on Assets (ttm) | 14.71% |
| Return on Equity (ttm) | 25.24% |
Income Statement
| Revenue (ttm) | 5.54B USD |
| Revenue Per Share (ttm) | 9.48 USD |
| Quarterly Revenue Growth (yoy) | 10.80% |
| Gross Profit (ttm) | 3.44B USD |
| EBITDA | 2.12B USD |
| Net Income Avi to Common (ttm) | 1.52B USD |
| Diluted EPS (ttm) | 1.04 |
| Quarterly Earnings Growth (yoy) | 9.19% |
Balance Sheet
| Total Cash (mrq) | 1.66B USD |
| Total Cash Per Share (mrq) | 2.86 USD |
| Total Debt (mrq) | 843.17M USD |
| Total Debt/Equity (mrq) | 12.99 USD |
| Current Ratio (mrq) | 3.008 |
| Book Value Per Share (mrq) | 11.18975 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.89B USD |
| Levered Free Cash Flow (ttm) | 1.45B USD |
Profile of ResMed Inc.
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 9001 Spectrum Center Boulevard |
| ZIP | 92123 |
| Phone | 858-836-5000 |
| Website | https://www.resmed.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 10600 |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Q&A For ResMed Inc. Stock
What is a current RSMDF stock price?
ResMed Inc. RSMDF stock price today per share is 16.99 USD.
How to purchase ResMed Inc. stock?
You can buy RSMDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ResMed Inc.?
The stock symbol or ticker of ResMed Inc. is RSMDF.
Which industry does the ResMed Inc. company belong to?
The ResMed Inc. industry is Medical Instruments & Supplies.
How many shares does ResMed Inc. have in circulation?
The max supply of ResMed Inc. shares is 1.45B.
What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?
ResMed Inc. PE Ratio is 16.33653800 now.
What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?
ResMed Inc. EPS is 1.04 USD over the trailing 12 months.
Which sector does the ResMed Inc. company belong to?
The ResMed Inc. sector is Healthcare.


